Neighbor News
Cambridge BioMarketing Named To Boston Globe's Top 100 Women Led Businesses
Second Year For World's Leading Orphan and Specialty Communications Agency
CAMBRIDGE, Mass. -- Cambridge BioMarketing (CB), a full-service healthcare marketing communications agency focused on orphan and specialty pharmaceuticals and led by Wellesley, Mass resident Maureen Franco, has been named to the Boston Globe’s Top 100 Women-Led Businesses for the second year in a row.
Prior to joining CB in 2012, Ms. Franco, who is partner and CEO, spent 12 years at Genzyme in Cambridge, Mass. where, most recently, she was VP Global Marketing in their rare genetic disease division. She began her career in healthcare public relations and pharmaceutical advertising in Boston and Chicago.
The Globe partnered with the Commonwealth Institute (TCI) to present the institute’s 13th annual list. The List appeared online and in the Globe Magazine’s Women and Power Issue where CB was ranked #35 on the list up from #63 in 2013.
Find out what's happening in Wellesleyfor free with the latest updates from Patch.
During her tenure, Cambridge BioMarketing has doubled its employee count from 30 to 60 and has expanded its Kendall Square headquarters to accommodate this growth and to serve their growing client roster.
The Commonwealth Institute conducts a survey each year to identify and rank the Top 100 Women-Led Businesses in Massachusetts, based on annual revenue and for the first time, added other variables: number of full-time employees in the state, workplace and management diversity, and innovative projects.
Find out what's happening in Wellesleyfor free with the latest updates from Patch.
“It’s no surprise to us that women are the fuel helping drive the economic engine in Massachusetts,” said Aileen Gorman, executive director of TCI. “There is no sector where women leaders are not represented; we and the Boston Globe Magazine are excited to celebrate this, and we hope this also inspires other women to strive for leadership positions in our region.”
About Cambridge BioMarketing
Founded in 2001, Cambridge BioMarketing is the world’s leading orphan and specialty communications agency. Having launched some of the most successful orphan and ultra-orphan products ever, Cambridge culture reflects its clients’ extraordinary drive to deliver life-changing medicines to those who need them most: people and families facing devastating, underappreciated diseases. For more information about the agency and its mission, please visit www.cambridgebmg.com.
